Skip to main content

Posts

  • China is promoting coronavirus treatments based on unproven traditional medicines

    7 May, 2020
    Scientists say rigorous trial data are needed to show that remedies are safe and effective
    The Chinese government is heavily promoting traditional medicines as treatments for COVID-19. The remedies, a major part of China’s health-care system, are even being sent to countries including Iran and Italy as international aid. But scientists outside China say it is dangerous to support therapies that have yet to be proved safe and effective.





    There are currently no proven t...
  • Rapid development of an inactivated vaccine candidate for SARS-CoV-2

    7 May, 2020
    The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) has resulted in an unprecedented public health crisis. There are currently no SARS-CoV-2-specific treatments or vaccines available due to the novelty of the virus. Hence, rapid development of effective vaccines against SARS-CoV-2 are urgently needed. Here we developed a pilot-scale production of a purified inactivated SARS-CoV-2 virus vaccine candidate (PiCoVacc), which indu...
  • Coronavirus Product Design and 3D Printing Challenge (open source designs)

    6 May, 2020

    With the outbreak of Coronavirus; testing, social distancing, and handwashing have helped prevent the spread of this disease. One area responsible for the further spread is frequently touched surfaces in offices, stores, and workplace areas (i.e. door handles).

    We believe the Cad Crowd community can help prevent the spread by creating open-source product designs for public spaces.

    The contest involves creating products that will be shared under a publicly downloadable open s...
  • Engineers from Colorado will design medical-grade, mass-producible masks for COVID-19 response

    6 May, 2020

    Colorado State University engineers are now poised to help fulfill projected demand for close to 50,000 medical masks per day for nurses, doctors and other health care providers. In support of their efforts, they’ve received a $25,000 grant from the Colorado Clinical and Translational Sciences Institute under the COVID-19-Related Research Pilot program,, which just announced four statewide winners out of over 50 applicants.









    The CSU team led by David ...
  • The Virustatic Shield

    6 May, 2020

    Brand new Virustatic Shield gives anti-viral protection for you and your family. The easy-to-wear snood helps prevent infection.

    The coating is designed to be applied to single-layer materials for pandemic situations. The coating transforms the base material into an anti-viral, multi-functional protective snood. So light and breathable you won’t believe its virus stopping power. Proven to trap and kill airborne enveloped influenza viruses.

    Click here for reference

  • Coronavirus lockdown: Inventive routes back to normal life

    6 May, 2020

    Across the world, countries are embarking on enormous experiments in ending coronavirus lockdown measures - and others are looking on nervously, asking themselves what's the best way back to normality.

    There's no international consensus over how best to do it - but we've looked at the key trends that are emerging, and some of the innovative thinking leading the way.

    Click here for reference










  • Young US couple creates innovative system to clean and reuse N95 masks with hydrogen peroxide

    6 May, 2020
    A young couple in Columbus, Ohio, came up with a unique way to clean and reuse critically needed N95 masks. This breakthrough system rolling out across the country provides some relief for health care workers struggling with a lack of personal protective equipment.Click here for reference







  • Airway management for COVID-19: a move towards universal videolaryngoscope?

    6 May, 2020
    Considering that any patient who is admitted to the intensive care unit (ICU) might be infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we present a video of tracheal intubation performed in an operating room, using two different devices for laryngoscopy (video). As recommended by airway management societies worldwide, we used a rapid sequence induction, and face mask ventilation was avoided. In part 1 of the video, the use of standard Macintosh laryngoscope for tra...
  • Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19

    6 May, 2020
    Coronavirus disease 2019 (COVID-19) was announced a pandemic by WHO on March 11, 2020. As of May 3, 2020, Italy is one of the countries hit hardest by the COVID-19 pandemic, with 28 884 confirmed deaths. In addition to pulmonary insufficiency, COVID-19 is associated with other life-threatening complications such as sepsis, heart failure, and pulmonary embolism. Here we describe patients with COVID-19 who presented with acute limb ischaemia but did not have atherosclerosis, atrial fibrillation...
  • SARS-COV-2 was already spreading in France in late December 2019

    6 May, 2020

    The COVID-19 epidemic is believed to have started in late January 2020 in France. We report here a case of a patient hospitalized in December 2019 in our intensive care, of our hospital in the north of Paris, for hemoptysis with no etiological diagnosis and for which RT-PCR was performed retrospectively on the stored respiratory sample which confirmed the diagnosis of COVID-19 infection. Based on this result, it appears that the COVID-19 epidemic started much earlier.


    Click her...
  • The race is on for antibodies that stop the new coronavirus

    6 May, 2020

    Dr. X could not help her sick family members, but her eagerness to do something grew. She knew that in China, plasma from recovered people, which contains antibodies to the virus, was showing promise as a treatment. Her doctor told her about a project, a collaboration between Vanderbilt University and AstraZeneca, to develop something safer and more powerful. It aims to go beyond the mishmash of antibodies in convalescent plasma and pull out the equivalent of a guided missile: an antibody...
  • Grifols completes development of very high sensitivity molecular test to detect SARS-CoV-2 virus

    6 May, 2020
    The company has developed the test in record time in a global coordinated effort of its facilities in San Diego, Barcelona and Bilbao, and has recently received the authorization of the Spanish Medicines and Medical Devices Agency (AEMPS) for its use in blood, plasma and respiratory samples. It has a sensitivity equal or even superior to that of other molecular tests currently available, such as those based on PCR.


    Thanks to this high sensitivity, the molecular test will also permi...